FOLASSIST
DEAD

Serial Number

86724545

Owner

ALLERGAN FINANCE, LLC

Attorney

Matthew O. Brady

Filing Date

Aug 13, 2015

Add to watchlist:

No watchlists yet
View on USPTO

FOLASSIST Trademark

Serial Number: 86724545

FOLASSIST is a trademark filed by ALLERGAN FINANCE, LLC on August 13, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ALLERGAN FINANCE, LLC (37 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 16

ACTAVIS, INC. (216 trademarks)

400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

August 13, 2015

Registration Date

Not Registered

Published for Opposition

November 3, 2015

Goods & Services

Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 4, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 4, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 19, 2018 EXRA
SOU EXTENSION 5 GRANTED
Jun 18, 2018 EX5G
SOU EXTENSION 5 FILED
Jun 14, 2018 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 14, 2018 EEXT
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 3, 2018 ASCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2017 EXRA
SOU EXTENSION 4 GRANTED
Dec 1, 2017 EX4G
SOU EXTENSION 4 FILED
Dec 1, 2017 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 1, 2017 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 28, 2017 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 16, 2017 EXRA
SOU EXTENSION 3 GRANTED
Jun 15, 2017 EX3G
SOU EXTENSION 3 FILED
Jun 12, 2017 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 12, 2017 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 30, 2017 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 24, 2016 EXRA
SOU EXTENSION 2 GRANTED
Dec 23, 2016 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 22, 2016 AITU
SOU EXTENSION 2 FILED
Dec 2, 2016 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 2, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2016 EXRA
SOU EXTENSION 1 GRANTED
Jun 24, 2016 EX1G
SOU EXTENSION 1 FILED
Jun 24, 2016 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 24, 2016 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 29, 2015 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 3, 2015 NPUB
PUBLISHED FOR OPPOSITION
Nov 3, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 14, 2015 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2015 CNSA
ASSIGNED TO EXAMINER
Sep 21, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2015 NWOS
NEW APPLICATION ENTERED
Aug 17, 2015 NWAP